These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9528894)

  • 21. Progressive polarization towards a T helper/cytotoxic type-1 cytokine pattern during age-dependent maturation of the immune response inversely correlates with CD30 cell expression and serum concentration.
    Krampera M; Vinante F; Tavecchia L; Morosato L; Chilosi M; Romagnani S; Zanolin ME; Pizzolo G
    Clin Exp Immunol; 1999 Aug; 117(2):291-7. PubMed ID: 10444260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitation of chemokines (MDC, TARC) expression in mucosa from Crohn's disease and ulcerative colitis.
    Jugde F; Alizadeh M; Boissier C; Chantry D; Siproudhis L; Corbinais S; Quelvennec E; Dyard F; Campion JP; Gosselin M; Bretagne JF; Sémana G; Heresbach D
    Eur Cytokine Netw; 2001; 12(3):468-77. PubMed ID: 11566628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of a splice variant of CXCR3 in Crohn's disease patients; indication for a lymphocyte--epithelial cell interaction.
    Manousou P; Kolios G; Drygiannakis I; Pyrovolaki K; Bourikas L; Papadaki HA; Kouroumalis E
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1823-33. PubMed ID: 18761554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phagocytosis, killing, lymphocyte-mediated antibacterial activity, serum autoantibodies, and plasma endotoxins in inflammatory bowel disease.
    Caradonna L; Amati L; Lella P; Jirillo E; Caccavo D
    Am J Gastroenterol; 2000 Jun; 95(6):1495-502. PubMed ID: 10894586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T lymphocyte subsets in inflammatory bowel disease: peripheral blood.
    Selby WS; Jewell DP
    Gut; 1983 Feb; 24(2):99-105. PubMed ID: 6221976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different regulation of eosinophil activity in Crohn's disease compared with ulcerative colitis.
    Lampinen M; Backman M; Winqvist O; Rorsman F; Rönnblom A; Sangfelt P; Carlson M
    J Leukoc Biol; 2008 Dec; 84(6):1392-9. PubMed ID: 18801925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Divergent cell cycle kinetics underlie the distinct functional capacity of mucosal T cells in Crohn's disease and ulcerative colitis.
    Sturm A; Leite AZ; Danese S; Krivacic KA; West GA; Mohr S; Jacobberger JW; Fiocchi C
    Gut; 2004 Nov; 53(11):1624-31. PubMed ID: 15479683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD30 and type 2 T helper (Th2) responses.
    Romagnani S; Del Prete G; Maggi E; Chilosi M; Caligaris-Cappio F; Pizzolo G
    J Leukoc Biol; 1995 May; 57(5):726-30. PubMed ID: 7759952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune functions in inflammatory bowel and coeliac diseases.
    Soppi E; Eskola J; Lehtonen OP; Leino R
    APMIS; 1988 Sep; 96(9):850-6. PubMed ID: 3166811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pokeweed mitogen stimulated immunoglobulin production by peripheral blood lymphocytes in vitro: evidence for disordered immunoregulation in patients with ulcerative colitis and Crohn's disease.
    Danis VA; Heatley RV
    Clin Exp Immunol; 1983 Dec; 54(3):739-46. PubMed ID: 6606515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serology of Patients with Ulcerative Colitis After Pouch Surgery Is More Comparable with that of Patients with Crohn's Disease.
    Goren I; Yahav L; Tulchinsky H; Dotan I
    Inflamm Bowel Dis; 2015 Oct; 21(10):2289-95. PubMed ID: 26197448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro IgE production by peripheral blood lymphocytes and rectal mucosal biopsies and antigen-induced basophil degranulation in patients with inflammatory bowel disease.
    Smart C; Danis VA; Heatley RV
    J Clin Lab Immunol; 1986 Aug; 20(4):183-5. PubMed ID: 3761355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunomodulatory effects of 1,25-dihydroxyvitamin D3 on TH1/TH2 cytokines in inflammatory bowel disease: an in vitro study.
    Ardizzone S; Cassinotti A; Trabattoni D; Manzionna G; Rainone V; Bevilacqua M; Massari A; Manes G; Maconi G; Clerici M; Bianchi Porro G
    Int J Immunopathol Pharmacol; 2009; 22(1):63-71. PubMed ID: 19309553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum tumor necrosis factor activity in inflammatory bowel disease.
    Maeda M; Watanabe N; Neda H; Yamauchi N; Okamoto T; Sasaki H; Tsuji Y; Akiyama S; Tsuji N; Niitsu Y
    Immunopharmacol Immunotoxicol; 1992; 14(3):451-61. PubMed ID: 1517530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased spontaneous secretion of rheumatoid factor by intestinal lamina propria mononuclear cells from Crohn's disease but not ulcerative colitis patients.
    MacDermott RP; Schreiber S; Nash GS; Koopman WJ
    Clin Exp Immunol; 1993 Apr; 92(1):152-7. PubMed ID: 8467559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of endoplasmic reticulum stress on the expression of inflammatory cytokines in patients with ulcerative colitis.
    Li N; Wang XM; Jiang LJ; Zhang M; Li N; Wei ZZ; Zheng N; Zhao YJ
    World J Gastroenterol; 2016 Feb; 22(7):2357-65. PubMed ID: 26900298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thymosin-dependent T-lymphocyte response in inflammatory bowel disease.
    Dopp AC; Mutchnick MG; Goldstein AL
    Gastroenterology; 1980 Aug; 79(2):276-82. PubMed ID: 6967439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Neopterin in assessing the activity of inflammatory bowel diseases: ulcerative colitis and Crohn's disease].
    Ciećko-Michalska I; Fedak D; Mach T
    Przegl Lek; 2010; 67(12):1262-5. PubMed ID: 21591350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating soluble interleukin-2 receptor alpha and beta chain in inflammatory bowel disease.
    Nielsen OH; Ciardelli T; Wu Z; Langholz E; Kirman I
    Am J Gastroenterol; 1995 Aug; 90(8):1301-6. PubMed ID: 7639234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T-cell immunoregulation in patients with inflammatory bowel disease. II. Enhanced suppressor T-cell activity in ulcerative colitis.
    Kramer JK; Depew WT; Szewczuk MR
    J Clin Lab Immunol; 1988 Jan; 25(1):19-27. PubMed ID: 2968458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.